2025-08-29 - Analysis Report
Okay, here's a report analyzing SDGR (Schrodinger Inc) based on the provided data.

**Report: SDGR (Schrodinger Inc) Analysis**

Schrodinger Inc. is a company that develops software for drug discovery and materials science.

**1. Performance vs. S&P 500 (VOO)**

*   **Cumulative Return (SDGR):** -53.98%
*   **Cumulative Return (VOO):** 58.71%
*   **Deviation:** -124.2
*   **Relative Deviation:** 0.6 (Indicates the current deviation is near the lowest end of its historical range.)

**Analysis:** SDGR has significantly underperformed the S&P 500 (VOO) over the specified period. The relative deviation suggests that this underperformance is near the lowest it has been historically.

**Alpha/Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha   | Beta   | Cap(B) |
|------------|--------|--------|---------|--------|--------|
| 2020-2022  | -74.0% | 68.9%  | -89.0%  | -0.1   | 1.4    |
| 2021-2023  | -65.0% | 68.9%  | -83.0%  | -0.0   | 2.6    |
| 2022-2024  | 8.0%   | 72.4%  | -17.0%  | -0.0   | 1.4    |
| 2023-2025  | -1.0%  | 74.0%  | -55.0%  | -0.0   | 1.4    |

**Analysis:**

*   **CAGR:** Schrodinger's CAGR is largely negative for all periods observed.
*   **MDD:** High MDD values indicate significant drawdowns.
*   **Alpha:** Significantly negative Alpha values suggests underperformance relative to the market risk-adjusted return, meaning the company hasn't rewarded its investors.
*   **Beta:** Beta values close to zero indicates very low correlation with market movements.
*   **Cap(B):** Market capitalization is low for all periods.

**2. Recent Price Action**

*   **Current Price:** \$19.76
*   **Previous Close:** \$19.79
*   **Change:** -\$0.15
*   **5-Day Moving Average:** \$19.81
*   **20-Day Moving Average:** \$19.53
*   **60-Day Moving Average:** \$21.08

**Analysis:** The current price is slightly below the 5-day moving average and the previous close, and above the 20-day moving average, but below the 60-day moving average. The small negative change in price suggests a slight downward trend in the very short term.

**3. Technical Indicators & Expected Return**

*   **Market Risk Indicator (MRI):** 0.33 (Low Risk)
*   **RSI:** 54.88
*   **PPO:** 0.53
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (1 shares - Safe - MRI:0.32)
*   **Recent (20-day) Relative Deviation Change:** -0.4 (Downward Trend)
*   **Expected Return (%):** -4223.5%

**Analysis:**

*   **MRI:** The MRI suggests the market risk is low.
*   **RSI:** The RSI is near the middle, indicating neutral momentum.
*   **PPO:** The PPO is positive, suggesting the short-term moving average is slightly above the long-term moving average.
*   **Hybrid Signal:** The hybrid signal recommends buying 90% of available cash, suggesting a bullish but cautious approach.
*   **Deviation Change:** The recent negative change in relative deviation indicates a short-term downward trend.
*   **Expected Return:** The extremely negative expected return is a significant red flag, suggesting a very pessimistic outlook compared to S&P 500.

**4. Recent News & Significant Events**

*   **2025-08-25:** SDGR has recently made headlines due to major business developments, regulatory changes, or market events.
*   **2025-08-27:** Analysts are discussing SDGR's recent performance and its outlook.
*   **2025-08-28:** SDGR's stock has shown notable volatility.
*   **2025-08-26:** Market experts highlight both risks and opportunities for SDGR.

**Analysis:** The news suggests a period of significant activity and uncertainty surrounding SDGR. Volatility is present, and analysts are actively discussing the company's outlook. Investors should monitor company announcements.

**5. Recent Earnings Analysis**

| Date       | EPS   | Revenue    |
|------------|-------|------------|
| 2025-08-06 | -0.59 | \$0.05B    |
| 2025-05-07 | -0.82 | \$0.06B    |
| 2024-11-12 | -0.52 | \$0.04B    |
| 2024-07-31 | -0.74 | \$0.05B    |
| 2025-08-06 | -0.74 | \$0.05B    |

**Analysis:** SDGR consistently reports negative EPS. Revenue is relatively stable but low. This indicates ongoing losses for the company.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-06-30   | \$0.05B   | 47.77%        |
| 2025-03-31   | \$0.06B   | 52.26%        |
| 2024-12-31   | \$0.09B   | 72.61%        |
| 2024-09-30   | \$0.04B   | 50.24%        |
| 2024-06-30   | \$0.05B   | 66.20%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE    |
|--------------|-----------|--------|
| 2025-06-30   | \$0.34B   | -12.59% |
| 2025-03-31   | \$0.37B   | -16.01% |
| 2024-12-31   | \$0.42B   | -9.54%  |
| 2024-09-30   | \$0.45B   | -8.49%  |
| 2024-06-30   | \$0.47B   | -11.40% |

**Analysis:** Revenue fluctuates, but profit margins appear relatively strong. Equity is decreasing over the observed period. ROE is consistently negative, reflecting the company's inability to generate profit from shareholder equity.

**7. Overall Assessment**

Based on the data provided, SDGR presents a high-risk investment.

*   **Underperformance:** It has significantly underperformed the S&P 500.
*   **Negative Profitability:** The company is consistently losing money, reflected in negative EPS and ROE.
*   **High Risk:** The expected return is extremely negative. Recent news suggests volatility and uncertainty.
*   **Technical Indicators:** While the MRI suggests low market risk, other indicators like RSI and PPO offer a mixed picture.

**Recommendation:** Due to the significant underperformance, negative profitability, and pessimistic outlook, caution is strongly advised regarding investment in SDGR. Further in-depth analysis of the company's business developments, financial health, and future prospects is warranted before considering any investment.

